Exabis Library
Welcome to the e-CCO Library!
P323: The Rate of and Risk of Dysplasia in Long Standing Ulcerative Colitis Patients Among Middle-Eastern Population
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P324 Deep enteroscopy after balloon dilatation for differential diagnosis of small bowel stricture
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P324: Comparative short and long-term efficacy of infliximab and adalimumab in patients with ulcerative colitis refractory to corticosteroids: a retrospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P324: Evaluation of ability to predict mucosal healing by quantitative fecal immunochemical test in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P324: Inter- and intra-observer variation of capsule endoscopic findings for the diagnosis of Crohn’s disease: A case–control study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P324: Long-term impact of the COVID-19 pandemic on Inflammatory Bowel Disease healthcare utilization: A two-year nationwide update
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P324: Predictors of corticosteroid-free remission after initiation of ustekinumab for ulcerative colitis: a real-world, multicenter cohort study in the United States
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P324: Tacrolimus for induction of remission in refractory ulcerative colitis: a Cochrane systematic review
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P324: Tuberculosis infection under anti-TNF therapy – should we be looking for it?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P325 A propensity score-weighted comparison of vedolizumab and adalimumab in Crohn’s disease: Real-life data from the Sicilian Network for inflammatory bowel disease (SN-IBD)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P325: Combination therapy with adalimumab and immunomodulators decreases incidence of intestinal resection in Crohn's disease patients previously treated with infliximab: a large, multicentre cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P325: Efficacy, safety, and long-term outcome of endoscopic dilation therapy for stricturing Crohn’s disease of the upper gastrointestinal tract: a combined analysis of 127 endoscopic balloon dilation procedures
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P325: Integrating efficacy and safety of vedolizumab and other advanced therapies for the treatment of ulcerative colitis: Results from a network meta-analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P325: Performance of new MRI scores: the modified Van Assche Index and the MAGNIFI-CD in the evaluation of the response to anti-TNFα in anoperineal fistulas in Crohn's disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P325: Proton pump inhibitors are associated with a disabling course of Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P325: Real-World Effectiveness And Safety Of Ustekinumab In Patients With Ulcerative Colitis: A Multi-Centre Study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P325: Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P326: An exploratory analysis of the impact of COVID-19 on colonoscopy procedures and new biologic treatment initiation among patients with Inflammatory Bowel Disease in the United States
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P326: Audit and review of infliximab therapeutic drug monitoring and prescribing practices in paediatric inflammatory bowel disease (IBD) patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM